-
Front Oncol: Efficacy of lenvatinib vs. Sorafenib in the treatment of advanced hepatocellular carcinoma: Propensity score matching (PSM) analysis
Time of Update: 2021-11-12
After PSM matching, the median PFS of lenvatinib was still significantly longer than that of sorafenib group (5.
After PSM matching, the median PFS of lenvatinib was still significantly longer than that of sorafenib group (5.
-
Shanghai Lingang Carbon Valley Green Bay first project launched
Time of Update: 2021-10-20
Recently, Shanghai Lingang Group and Shanghai Jinshan District Government launched the Lingang Carbon Valley Green Bay first project in Jinshan Second Industrial Zone, aiming at the national dual-carbon and dual-cycle strategy and Shanghai’s "14th Five-Year Plan" The development direction of the "South-North Transformation" industry will work hand in hand to create a new industrial highland .
-
PhRMA: More than 1650 clinical trials are underway for COVID-19 treatments and vaccines
Time of Update: 2020-11-08
."The World Health Organization's International Clinical Trials Registration Platform, as detailed in the biopharmaceutical industry has made significant progress in developing potential vaccines, although COVID-19 was only identified in December 2019.
-
Uncovers the determinants of bacterial size and deduces a new "individual growth split equation
Time of Update: 2020-08-04
coli as a model organism, debunks the determinants of bacterial size, deduces a new "individual growth and division equation", corrects the two original growth rules in the field, and provides a basis for the rational design of life in the field of synthetic biology.
